9. February 2010 04:49
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
[More]
9. February 2010 04:25
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that will generate an additional $800,000 in contract revenue for Corgenix over the life of the contract.
[More]
111ace1b-e1a8-40c7-8a1c-b6b5e6d81432|0|.0
Posted in: Medical Research News | Disease/Infection News
Tags: Antibody, Arthritis, Biotechnology, Cancer, Cardiovascular Disease, Cellular Biology, Dermatology, Education, Hemorrhagic Fever, Hospital, Immunology, Lassa Virus, Monoclonal Antibody, Pediatrics, Vaccine, Virus
9. February 2010 03:05
Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.
[More]
9. February 2010 01:26
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.
[More]
583be827-9d68-4e11-8384-68ff80752893|0|.0
Posted in: Drug Trial News | Disease/Infection News
Tags: Allergy, Antibody, Antiretroviral, Biotechnology, CDC, Cell, DNA, HIV/AIDS, New Drug Application, Recombinant DNA, RNA, Vaccine, Virus
8. February 2010 07:58
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
[More]
284d6ee5-27bd-4c39-9c00-06817c0a4ecb|0|.0
Posted in: Drug Trial News | Women's Health News
Tags: Antibody, Avian Influenza, Cancer, Cell, Cervical Cancer, DNA, Gardasil, Gene Expression, Immunization, Influenza, Vaccine, Virus
8. February 2010 03:07
Novavax, Inc. announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in the country of Spain.
[More]
8. February 2010 01:50
A parent's existing health habits or behaviors, like cigarette smoking, may influence the likelihood that they will have their daughters vaccinated against HPV.
[More]
6. February 2010 03:58
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) brings attention to a certain previously released news announcements namely January 7 2009, November 19, 2009, Dec 15, 2009 January 12,2010, and January 22, 2010.
[More]
6. February 2010 02:15
High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, researchers report in a new study published online February 5 in the Journal of the National Cancer Institute. Some of these genital abnormalities are precursors of cervical, vulvar, and vaginal cancers.
[More]
6. February 2010 01:44
Groundbreaking research done at Singapore's Nanyang Technological University's (NTU) School of Biological Sciences (SBS) could lead to the development of more potent drugs or a vaccine for malaria, which is transmitted to humans by infected mosquitoes and kills up to three million people each year.
[More]
6. February 2010 01:38
The latest poll from researchers at the Harvard School of Public Health (HSPH) shows that almost half of Americans believe the H1N1 flu outbreak is over (44%), and levels of concern about getting sick with the virus continue to decline.
[More]
5. February 2010 07:58
When hockey fans converge at this Sunday's Ottawa 67's game, Garry Galley, former NHL defenseman and current analyst of Hockey Night in Canada, will team up with Dr. Gary Garber to share defense tips about the four vaccine-preventable strains of meningococcal meningitis with hockey enthusiasts at the Take a Shot for Meningitis Awareness booth. The pair will educate hockey enthusiasts and their families about meningococcal meningitis prevention and protection.
[More]
5. February 2010 06:13
Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children.
[More]
5. February 2010 04:05
Research and Markets(http://www.researchandmarkets.com/research/ed1690/china_disposable_v) has announced the addition of the "China Disposable Vaccine Syringe Market Analysis 2009" report to their offering.
[More]
5. February 2010 03:18
A new report, Adult Immunization: Shots to Save Lives, released today by the Trust for America's Health (TFAH), the Infectious Diseases Society of America (IDSA), and the Robert Wood Johnson Foundation (RWJF) found that more than 30 percent of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008.
[More]
c43dbfdd-34ee-45c3-b27a-6d1e66140973|0|.0
Posted in: Disease/Infection News | Pharmaceutical News
Tags: Cancer, CDC, Cough, Diphtheria, Education, Health Reform, Immunization, Medicare, Pneumonia, Seniors, Tetanus, Vaccine, Whooping Cough
Subscribe